Hostname: page-component-cd9895bd7-7cvxr Total loading time: 0 Render date: 2024-12-21T14:52:31.562Z Has data issue: false hasContentIssue false

P0092 - Clinical and self-perceived health status in outpatients with generalized anxiety disorders (GAD) followed in psychiatric clinics: A Spanish perspective

Published online by Cambridge University Press:  16 April 2020

L. Caballero
Affiliation:
Department of Psychiatry, University Hospital “Puerta de Hierro”, Madrid, Spain
J. Bobas
Affiliation:
Department of Medicine, School of Medicine, University of Oviedo, Asturias, Spain
M. Perez
Affiliation:
Neurosciences Department, Medical Unit, Pfizer Spain, Alcobendas, Madrid, Spain
I. Vilardaga
Affiliation:
Biometric Department, European Biometric Institute, Barcelona, Spain
J. Rejas
Affiliation:
Health Outcomes Research Department, Medical Unit, Pfizer Spain, Alcobendas, Madrid, Spain

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Objective:

analyse GAD impact on clinical and self-perceived health status in outpatients followed in Psychiatric clinics.

Methods:

Multicentre, cross-sectional study enrolling subjects above 18 years-old with GAD according with ICD-10. Participants were chosen at ramdon by quotes and weighted geographically, but patients were enrolled consecutively. HAM-A and CGI-S were administered to determine clinical status and SF-36 and Sheehan disability scales for health status assessment.

Results:

A total of 792 patients; 15.7% naives (GADn), 68.9% women, mean (SD) age of 40.0 (12.9) years were included. Time to effective diagnosis and start up of treatment were, respectively, 2.3 (4.9) and 2.6 (4.7) years. Severe symtoms of anxiety (HAM-A > 24) were presented in 45.2%; 56.9% in GADn vs 43.0% on-treatment (GADt), p<0.001. CGI-S was 3.7 (1.1) in GADn vs. 4.2 (0.8) in GADt, p<0.001. The 77,7% of GADt were receiving 2 or more drugs: 94.1% ansiolytics and/or antidepressants. The 39.3% of subjects showed high/extreme disability for work; 44.4% GADn vs 38.5% GADt, p=0.33, 34.5% for daily-living domestic activities; 39.7% vs 33.7% respectively, p=0.082, and 41.8% for social life; 43.1% vs 41.7% respectively, p=0,145. Mental composite summary of SF-36 was below normal; 30,0 (11,4), much lower in GADn: 25,4 (8,5) vs. 30,8 (11,7), p<0.001. No gender differences were found.

Conclusions:

This study showed that a considerable proportion of GAD patients still need for additional medical remedies which should improve the level of disability caused by the diasease and counteract the deteriorated mental health observed in such patients.

Type
Poster Session II: Anxiety Disorders
Copyright
Copyright © European Psychiatric Association 2008
Submit a response

Comments

No Comments have been published for this article.